Similar Items: MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors
- The future of targeted therapies for pediatric central nervous system tumors
- Targeted therapies in adolescent and young adult patients with central nervous system tumors
- The use of botulinum toxin type A in the treatment of chronic drug-resistant pain in a patient with type 1 neurofibromatosis
- Eriochrome Cyanine R revisited: a standardized myelin stain protocol for thick sections of the central & peripheral nervous system across species, pathologies and disease models
- Effects of physical exercise on central nervous system functions: a review of brain region specific adaptations
- FGFR alterations and potential role of FGFR inhibitors in pediatric brain tumors